查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球獸用抗感染藥物市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按物種類型、按藥物類別、按管理模式、按分銷管道、按地區
市場調查報告書
商品編碼
1394132

全球獸用抗感染藥物市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按物種類型、按藥物類別、按管理模式、按分銷管道、按地區

Veterinary Anti-Infectives Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 232 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球獸用抗感染藥市場正在發生重大變化，北美成為利潤最高的地區。 這一趨勢的推動因素包括寵物擁有量的增加、動物飼養需求的增加以及對食品安全的日益擔憂。 此外，寵物保險的採用率正在上升，美國的參與率每年增長 10%，令人震驚。

北美市場以美國為主導，預計在預測期內將佔據超過75%的份額。 加拿大也表現出強勁的成長，預計複合年增長率為 4%。 北美市場佔有率預計將超過15億美元。

另一方面，亞太地區正在經歷快速成長，主要公司專注於促進小動物照護、蓬勃發展的畜牧業以及印度的銷售合作夥伴關係。

全球獸用抗感染藥物市場以抗菌藥物為主導，緊隨其後的是抗病毒藥物。 在抗菌藥物類別中，青黴素類、頭孢菌素類和四環素類成長速度較高。 抗病毒藥物預計將成為按藥物類別排名第二的最受青睞的細分市場，在評估期間市場吸引力指數為 1.2。

生物製劑和特殊藥物為全球獸用抗感染藥物市場的主要參與者提供了重大機會。 歷史上較低的研發回報正在推動新產品開發 (NPD) 的需求。 研究和開發，特別是生物製品和專業醫學的創新，提供了許多機會。 此外，治療藥物的可負擔性不斷提高以及消費者對寵物護理和牲畜的意識增強也提供了強勁的成長前景，特別是對於新進業者而言。

本報告調查了全球獸用抗感染藥物市場，並按品種類型、藥物類別、給藥方式、分銷渠道、區域趨勢和市場參與者提供了市場概況。它提供了有關公司競爭趨勢的信息。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2031年全球獸用抗感染藥物市場前景

  • 2018-2031 年全球獸用抗感染藥物市場前景（按物種類型、價值（百萬美元））
  • 2018-2031 年全球獸用抗感染藥物市場前景（依藥物類別、價值（百萬美元））
  • 2018-2031 年全球獸用抗感染藥物市場前景（以給藥方式劃分）、價值（百萬美元）
  • 2018-2031 年全球獸用抗感染藥物市場前景（按分銷管道）、價值（百萬美元）
  • 2018-2031 年全球獸用抗感染藥物市場前景（按地區、價值（百萬美元））

第四章2018-2031年北美獸用抗感染藥物市場前景

第五章歐洲獸用抗感染藥物市場前景，2018-2031

第六章2018-2031年亞太地區獸用抗感染藥物市場前景

第七章2018-2031年拉丁美洲獸用抗感染藥物市場展望

第8章2018-2031年中東及非洲獸用抗感染藥物市場前景

第九章競爭態勢

  • 依給藥模式和藥物類別劃分的熱圖
  • 按製造商和藥品類別劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Bayer AG
    • Cipla Limited
    • Dechra Pharmaceuticals PLC
    • Eli Lilly and Company (Elanco Animal Health)
    • Heska Corp (Diamond Animal Health)
    • Merck & Co., Inc. (Merck Animal Health)
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Sanofi (Merial Animal Health)
    • Vetoquinol S.A.
    • Virbac S.A.
    • Zoetis, Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale
    • Indian Immunologicals Limited
    • Intas Pharmaceuticals Limited
    • Norbrook Laboratories Limited
    • Zydus Animal Health Limited
    • Ashish Life Science Private Limited
    • Oceanic Pharmachem Private Limited.

第 10 章附錄

簡介目錄

The global veterinary anti-infectives market is witnessing a significant shift in dynamics, with North America emerging as the most lucrative region. This trend can be attributed to the increasing pet ownership, a rising demand for enhanced animal nutrition, and a heightened focus on food safety. Furthermore, the adoption of pet insurance is on the rise, with enrollment in the United States growing at an impressive 10% per year.

North America: A Lucrative Hub The United States market leads the way in North America, expected to represent over 75% share during the forecast period. Canada is also set to exhibit robust growth with a projected CAGR of 4%. North America is expected to reach a market value share of more than US$ 1500 Mn.

Asia Pacific: Rapid Expansion Meanwhile, the Asia Pacific (APAC) region is experiencing rapid growth driven by the promotion of small animal care, a thriving livestock segment, and key players focusing on distribution partnerships in India.

Segment Insights: The antimicrobial agents segment leads the global veterinary anti-infectives market, closely followed by antiviral agents. Within the antimicrobial agents category, Penicillins, Cephalosporins, and Tetracyclines account for a higher growth rate. The antiviral agents segment is anticipated to be the second most lucrative segment by drug class, showcasing a market attractiveness index of 1.2 during the assessment period.

Unveiling Opportunities Biologics and specialty care present significant opportunities for key players in the global veterinary anti-infectives market. Past low returns on research and development have spurred a demand for New Product Development (NPD). Innovation in research and development, particularly in biologics and specialty care, offers a plethora of opportunities. Moreover, the increasing affordability of therapeutics and growing consumer awareness about pet care and livestock contribute to significant growth prospects, especially for new market entrants.

Comprehensive Market Segmentation The veterinary anti-infectives market research report provides a comprehensive segmentation based on several attributes:

1. By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

2. By Species Type:

  • Livestock Animals
  • Companion Animals

3. By Drug Class:

  • Antimicrobial Agents
  • Tetracyclines
  • Penicillins
  • Cephalosporins
  • Macrolides
  • Quinolones
  • Others
  • Antiviral Agents
  • Antifungal Agents
  • Antiparasitic Agents
  • Others

4. By Mode of Administration:

  • Oral
  • Parenteral
  • Topical

5. By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies
  • Others

These segmentation attributes enable a deeper understanding of market dynamics, regional variations, sub-segment analysis, and more.

Table of Contents

1. Executive Summary

  • 1.1. Global Veterinary Anti-Infectives Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 3.1. Global Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Livestock Animals
      • 3.1.1.2. Companion Animals
  • 3.2. Global Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Antimicrobial Agents
        • 3.2.1.1.1. Tetracyclines
        • 3.2.1.1.2. Penicillins
        • 3.2.1.1.3. Cephalosporins
        • 3.2.1.1.4. Macrolides
        • 3.2.1.1.5. Quinolones
        • 3.2.1.1.6. Others
      • 3.2.1.2. Antiviral Agents
      • 3.2.1.3. Antifungal Agents
      • 3.2.1.4. Antiparasitic Agents
      • 3.2.1.5. Others
  • 3.3. Global Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oral
      • 3.3.1.2. Parenteral
      • 3.3.1.3. Topical
  • 3.4. Global Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Veterinary Hospitals
      • 3.4.1.2. Veterinary Clinics
      • 3.4.1.3. Pharmacies
      • 3.4.1.4. Others
  • 3.5. Global Veterinary Anti-Infectives Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 4.1. North America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Livestock Animals
      • 4.1.1.2. Companion Animals
  • 4.2. North America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Antimicrobial Agents
        • 4.2.1.1.1. Tetracyclines
        • 4.2.1.1.2. Penicillins
        • 4.2.1.1.3. Cephalosporins
        • 4.2.1.1.4. Macrolides
        • 4.2.1.1.5. Quinolones
        • 4.2.1.1.6. Others
      • 4.2.1.2. Antiviral Agents
      • 4.2.1.3. Antifungal Agents
      • 4.2.1.4. Antiparasitic Agents
      • 4.2.1.5. Others
  • 4.3. North America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oral
      • 4.3.1.2. Parenteral
      • 4.3.1.3. Topical
  • 4.4. North America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Veterinary Hospitals
      • 4.4.1.2. Veterinary Clinics
      • 4.4.1.3. Pharmacies
      • 4.4.1.4. Others
  • 4.5. North America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.2. U.S. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 4.5.1.3. U.S. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 4.5.1.4. U.S. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 4.5.1.5. Canada Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.6. Canada Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 4.5.1.7. Canada Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 4.5.1.8. Canada Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 5.1. Europe Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Livestock Animals
      • 5.1.1.2. Companion Animals
  • 5.2. Europe Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Antimicrobial Agents
        • 5.2.1.1.1. Tetracyclines
        • 5.2.1.1.2. Penicillins
        • 5.2.1.1.3. Cephalosporins
        • 5.2.1.1.4. Macrolides
        • 5.2.1.1.5. Quinolones
        • 5.2.1.1.6. Others
      • 5.2.1.2. Antiviral Agents
      • 5.2.1.3. Antifungal Agents
      • 5.2.1.4. Antiparasitic Agents
      • 5.2.1.5. Others
  • 5.3. Europe Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oral
      • 5.3.1.2. Parenteral
      • 5.3.1.3. Topical
  • 5.4. Europe Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Veterinary Hospitals
      • 5.4.1.2. Veterinary Clinics
      • 5.4.1.3. Pharmacies
      • 5.4.1.4. Others
  • 5.5. Europe Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.2. Germany Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.3. Germany Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.4. Germany Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.5. U.K. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.6. U.K. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.7. U.K. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.8. U.K. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.9. France Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.10. France Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.11. France Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.12. France Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.13. Italy Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.14. Italy Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.15. Italy Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.16. Italy Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.17. Turkey Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.18. Turkey Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.19. Turkey Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.20. Turkey Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.21. Russia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.22. Russia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.23. Russia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.24. Russia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Livestock Animals
      • 6.1.1.2. Companion Animals
  • 6.2. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Antimicrobial Agents
        • 6.2.1.1.1. Tetracyclines
        • 6.2.1.1.2. Penicillins
        • 6.2.1.1.3. Cephalosporins
        • 6.2.1.1.4. Macrolides
        • 6.2.1.1.5. Quinolones
        • 6.2.1.1.6. Others
      • 6.2.1.2. Antiviral Agents
      • 6.2.1.3. Antifungal Agents
      • 6.2.1.4. Antiparasitic Agents
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oral
      • 6.3.1.2. Parenteral
      • 6.3.1.3. Topical
  • 6.4. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Veterinary Hospitals
      • 6.4.1.2. Veterinary Clinics
      • 6.4.1.3. Pharmacies
      • 6.4.1.4. Others
  • 6.5. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.2. China Veterinary Anti-Infectives Market Sample Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.3. China Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.4. China Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.5. Japan Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.6. Japan Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.7. Japan Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.8. Japan Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.9. South Korea Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.10. South Korea Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.11. South Korea Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.12. South Korea Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.13. India Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.14. India Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.15. India Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.16. India Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 7.1. Latin America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Livestock Animals
      • 7.1.1.2. Companion Animals
  • 7.2. Latin America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Antimicrobial Agents
        • 7.2.1.1.1. Tetracyclines
        • 7.2.1.1.2. Penicillins
        • 7.2.1.1.3. Cephalosporins
        • 7.2.1.1.4. Macrolides
        • 7.2.1.1.5. Quinolones
        • 7.2.1.1.6. Others
      • 7.2.1.2. Antiviral Agents
      • 7.2.1.3. Antifungal Agents
      • 7.2.1.4. Antiparasitic Agents
      • 7.2.1.5. Others
  • 7.3. Latin America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oral
      • 7.3.1.2. Parenteral
      • 7.3.1.3. Topical
  • 7.4. Latin America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Veterinary Hospitals
      • 7.4.1.2. Veterinary Clinics
      • 7.4.1.3. Pharmacies
      • 7.4.1.4. Others
  • 7.5. Latin America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.2. Brazil Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.3. Brazil Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.4. Brazil Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.5. Mexico Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.6. Mexico Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.7. Mexico Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.8. Mexico Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.9. Argentina Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.10. Argentina Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.11. Argentina Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.12. Argentina Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Livestock Animals
      • 8.1.1.2. Companion Animals
  • 8.2. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Antimicrobial Agents
        • 8.2.1.1.1. Tetracyclines
        • 8.2.1.1.2. Penicillins
        • 8.2.1.1.3. Cephalosporins
        • 8.2.1.1.4. Macrolides
        • 8.2.1.1.5. Quinolones
        • 8.2.1.1.6. Others
      • 8.2.1.2. Antiviral Agents
      • 8.2.1.3. Antifungal Agents
      • 8.2.1.4. Antiparasitic Agents
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oral
      • 8.3.1.2. Parenteral
      • 8.3.1.3. Topical
  • 8.4. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Veterinary Hospitals
      • 8.4.1.2. Veterinary Clinics
      • 8.4.1.3. Pharmacies
      • 8.4.1.4. Others
  • 8.5. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.2. GCC Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.3. GCC Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.4. GCC Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.5. South Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.6. South Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.7. South Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.8. South Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.9. Egypt Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.10. Egypt Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.11. Egypt Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.12. Egypt Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.13. Nigeria Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.14. Nigeria Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.15. Nigeria Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.16. Nigeria Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Mode of Administration vs by Drug Class Heatmap
  • 9.2. Manufacturer vs by Drug Class Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Bayer AG
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Cipla Limited
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Dechra Pharmaceuticals PLC
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Eli Lilly and Company (Elanco Animal Health)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Heska Corp (Diamond Animal Health)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Merck & Co., Inc. (Merck Animal Health)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Neogen Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Phibro Animal Health Corporation
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Sanofi (Merial Animal Health)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Vetoquinol S.A.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Virbac S.A.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Zoetis, Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Boehringer Ingelheim GmbH
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Ceva Sante Animale
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Indian Immunologicals Limited
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Intas Pharmaceuticals Limited
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. Norbrook Laboratories Limited
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. Zydus Animal Health Limited
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development
    • 9.5.19. Ashish Life Science Private Limited
      • 9.5.19.1. Company Overview
      • 9.5.19.2. Product Portfolio
      • 9.5.19.3. Financial Overview
      • 9.5.19.4. Business Strategies and Development
    • 9.5.20. Oceanic Pharmachem Private Limited.
      • 9.5.20.1. Company Overview
      • 9.5.20.2. Product Portfolio
      • 9.5.20.3. Financial Overview
      • 9.5.20.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations